Formula shortage response

All of us at Prolacta Bioscience share the concern about the US infant formula shortage.

We are working at full capacity to ensure that hospitals, which may also be impacted by the shortage, have a continuous supply of our 100% human milk-based nutritional products for the critically ill, premature infants in their care.

We collect only enough donor milk to meet the needs of hospitals caring for medically fragile infants in the neonatal intensive care unit (NICU). Prolacta products are available by prescription only. They are not sold to the general public.

For information on donor breast milk that may be available to families facing the formula shortage, please visit https://www.hmbana.org/ or contact your local milk bank.